<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35153633</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1555-4155</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The journal for nurse practitioners : JNP</Title><ISOAbbreviation>J Nurse Pract</ISOAbbreviation></Journal><ArticleTitle>Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection.</ArticleTitle><Pagination><StartPage>335</StartPage><EndPage>338</EndPage><MedlinePgn>335-338</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nurpra.2021.12.016</ELocationID><Abstract><AbstractText>Postacute sequelae of SARS-CoV2 (PASC) infection is an emerging global health crisis, variably affecting millions worldwide. PASC has no established treatment. We describe 2 cases of PASC in response to opportune administration of over-the-counter antihistamines, with significant improvement in symptoms and ability to perform activities of daily living. Future studies are warranted to understand the potential role of histamine in the pathogenesis of PASC and explore the clinical benefits of antihistamines in the treatment of PASC.</AbstractText><CopyrightInformation>&#xa9; 2021 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Melissa D</ForeName><Initials>MD</Initials></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>Natalie</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Downs</LastName><ForeName>Charles A</ForeName><Initials>CA</Initials></Author><Author ValidYN="Y"><LastName>Abrahim</LastName><ForeName>Heather</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Thomas D</ForeName><Initials>TD</Initials></Author><Author ValidYN="Y"><LastName>Rahmani</LastName><ForeName>Amir M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Burton</LastName><ForeName>Candace W</ForeName><Initials>CW</Initials></Author><Author ValidYN="Y"><LastName>Chakraborty</LastName><ForeName>Rana</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Nurse Pract</MedlineTA><NlmUniqueID>101264817</NlmUniqueID><ISSNLinking>1555-4155</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 infection (PASC)</Keyword><Keyword MajorTopicYN="N">antihistamine</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">long-haul COVID</Keyword><Keyword MajorTopicYN="N">postacute SARS-CoV-2 infection (PASC)</Keyword><Keyword MajorTopicYN="N">treatment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>14</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35153633</ArticleId><ArticleId IdType="pmc">PMC8820139</ArticleId><ArticleId IdType="doi">10.1016/j.nurpra.2021.12.016</ArticleId><ArticleId IdType="pii">S1555-4155(21)00547-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4(2) doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert N., Survivor Corps El-Azab S.A., et al.  COVID-19 survivors&#x2019; report of the timing duration, and health impacts of Post-Acute Sequelae of SARS-CoV-2 (PASC) infection. MedRxiv. 2021 https://www.medrxiv.org/content/10.1101/2021.03.22.21254026v2 Accessed August 20, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.22.21254026v2</ArticleId><ArticleId IdType="pmc">PMC9538514</ArticleId><ArticleId IdType="pubmed">36181315</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Romieu C.A., Serena L., Armand M., et al. Health care utilization and clinical characteristics of non-hospitalized adults in an integrated health care system 28-180 days after COVID-19 diagnosis&#x2014;Georgia, May 2020&#x2013;March 2021. MMWR Morb Mortal Wkly Rep. 2021;70(17):644&#x2013;650. doi: 10.15585/mmwr.mm7017e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7017e3</ArticleId><ArticleId IdType="pmc">PMC8084119</ArticleId><ArticleId IdType="pubmed">33914727</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Pinto M.D., Borelli J.L., et al.  COVID symptoms, symptom clusters, and predictors for becoming a long-hauler: Looking for clarity in the haze of the pandemic. MedRxiv. 2021 https://www.medrxiv.org/content/10.1101/2021.03.03.21252086v1 Accessed August 20, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.03.21252086v1</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J., Long C.O.V.I.D. WHO calls on countries to offer patients more rehabilitation. BMJ. 2021;372:n405. doi: 10.1136/bmj.n405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n405</ArticleId><ArticleId IdType="pubmed">33568362</ArticleId></ArticleIdList></Reference><Reference><Citation>Malone R.W., Tisdall P., Fremont-Smith P., et al.  COVID-19: gamotidine, histamine, mast cells, and mechanisms. Front Pharmacol. https://doi.org/10.3389/fphar.2021.633680 Published online March 23, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.633680</ArticleId><ArticleId IdType="pmc">PMC8021898</ArticleId><ArticleId IdType="pubmed">33833683</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Narayan R.K., Kumari C., et al. Sars-Cov-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients. Med Hypotheses. 2020;145:110320. doi: 10.1016/j.mehy.2020.110320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110320</ArticleId><ArticleId IdType="pmc">PMC7525265</ArticleId><ArticleId IdType="pubmed">33032170</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Francisco E.B., Yogendra R., et al. Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. MedRxiv. 2021 doi: 10.1101/2021.06.25.449905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.25.449905</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long COVID: how to define it and how to manage it. BMJ. 2020;370:M3489. doi: 10.1136/bmj.m3489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogan R.B., 2nd, Hogan R.B., 3rd, Cannon T., et al. Dual-histamine receptor blockage with cetirizine-famotidine reduces pulmonary symptoms in COVID-19 patients. Pulm Pharmacol Ther. 2020;63:101942. doi: 10.1016/j.pupt.2020.101942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pupt.2020.101942</ArticleId><ArticleId IdType="pmc">PMC7455799</ArticleId><ArticleId IdType="pubmed">32871242</ArticleId></ArticleIdList></Reference><Reference><Citation>Ennis M., Tiligada K. Histamine receptors and COVID-19. Inflamm Res. 2021;70(1):67&#x2013;75. doi: 10.1007/s00011-020-01422-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01422-1</ArticleId><ArticleId IdType="pmc">PMC7673069</ArticleId><ArticleId IdType="pubmed">33206207</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenberg O., Martiny D., Rochas O., et al. Considerations for diagnostic COVID-19 testing. Nat Rev Microbiol. 2021;19:171&#x2013;183. doi: 10.1038/s41579-020-00461-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00461-z</ArticleId><ArticleId IdType="pmc">PMC7556561</ArticleId><ArticleId IdType="pubmed">33057203</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto M.D., Downs C.A., Lambert N., Burton C.W. How an effective response to post-acute sequelae of SAR-CoV2 Infection relies on nursing research. Res Nurs Health. 2021;44(5):743&#x2013;745. doi: 10.1002/nur.22176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nur.22176</ArticleId><ArticleId IdType="pmc">PMC8441745</ArticleId><ArticleId IdType="pubmed">34365670</ArticleId></ArticleIdList></Reference><Reference><Citation>Aucott J.N., Rebman A.W. Long-haul COVID: heed the lessons from other infection triggered illnesses. Lancet. 2021;397(10278):P967&#x2013;P968. doi: 10.1016/S0140-6736(21)00446-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00446-3</ArticleId><ArticleId IdType="pmc">PMC7952095</ArticleId><ArticleId IdType="pubmed">33684352</ArticleId></ArticleIdList></Reference><Reference><Citation>Denniston C., Molloy E., Rees C.E. &#x2018;I will never ever go back&#x2019;: patients written narrative of health care communication. Med Educ. 2018;52:757&#x2013;771. doi: 10.1111/medu.1361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/medu.1361</ArticleId><ArticleId IdType="pubmed">29879300</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>